Table 2.
Tumor response
Response according to irRC | Patients [n (%)] |
---|---|
irCR | 4 (3) |
irPR | 13 (9) |
irSD | 22 (15) |
Immune-related progressive disease | 106 (73) |
Immune-related best overall response rate | 17 (12) |
irDCR | 39 (27) |
irCR immune-related complete response, irDCR immune-related disease control rate, irPR immune-related partial response, irRC immune-related response criteria, irSD immune-related stable disease